Association between clinical characteristics and expression abundance of RTKN gene in human bladder carcinoma tissues from Chinese patients

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 3, 2005, Pages 157-162

  Fan, Jie ^a   Ma, Li Jie ^b   Xia, Shu Jie ^a   Yu, Long ^b   Fu, Qiang ^b   Wu, Chao Qun ^b   Huang, Xing Hua ^b   Jiang, Jian Ming ^b   Tang, Xiao Da ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Bladder neoplasm; Carciogenesis; Reverse transcription polymerase chain reaction; RTKN gene

Indexed keywords

MESSENGER RNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER GROWTH; CANCER STAGING; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL SIGNIFICANCE; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, TRANSITIONAL CELL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 12944324217     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0638-8     Document Type: Article

References (23)

1. Chen J, Yu L, Li D, Gao Q, Wang JS, Huang XH, Bi G, Wu H, Zhao SY (2003) Human, a novel enzyme-crystallin overoverexpressed in liver and kidney and downregulated in 58% of liver cancer tissues from Chinese patients, and four new homologs from other mammalians. Gene 302:103-113
2. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B (2002) Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 87:635-644
3. Fu Q, Yu L, Liu Q, Zhang J, Zhang H, Zhao S (2000) Molecular cloning, expression characterization, and mapping of a novel putative inhibitor of rho GTPase activity, RTKN, to D2S145-D2S286. Genomics 66:328-332
4. Fujiisawa K, Madaule P, Ishizaki T, Watanabe G, Bito H, Saito Y, Hall A,, Narumiya S (1998) Different regions of Rho determine Rho-selective binding of different classes of Rho target molecules. J Biol Chem 273:18943-18949
5. Gussow D, Rein R, Ginjaar I, Hochstenbach F, Seemann G, Kottman A, Ploegh HL (1987) The human beta-2-microglobulin gene: primary structure and definition of the transcriptional unit. J Immunol 139:3132-3138
6. Horiuchi A, Imai T, Wang C, Ohira S, Feng Y, Nikaido T, Konishi I (2003) Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 83:861-870
7. Jiang JM, Yu L, Huang XH, Chen X, Li D, Zhang YZ, Tang LS, Zhao SY (2001) Identification of two novel human dynein light chain genes, DNLC2A and DNLC2B, and their expression changes in hepatocellular carcinoma tissues from 68 Chinese patients. Gene 281:103-113
8. Kamai T, Arai K, Tsujii T, Honda M, Yoshida K (2001) Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour. BJU Int 87:227-231
9. Kamai T, Arai K, Sumi S, Tsujii T, Honda M, Yamanishi T, Yoshida KI (2002) The rho/rho-kinase pathway is involved in the progression of testicular germ cell tumour. BJU Int 89:449-453
10. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, Oshima H (2003) Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9:2632-2641
11. Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD (2002) Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 160:579-584
12. Narumiya S, Ishizaki T, Watanabe N (1997) Rho effectors and reorganization of actin cytoskeleton. FEBS Lett 410:68-72
13. waf/cip1. Nature 394:295-299
14. Ozaki I, Mizuta T, Zhao G, Yotsumoto H, Hara T, Kajihara S, Hisatomi A, Sakai T, Yamamoto K (2000) Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 60:6519-6525
15. Przybojewska B, Jagiello A, Jalmuzna P (2000) H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers. Cancer Genet Cytogenet 121:73-77
16. Reid D, furuyashiki T, Ishizakit T, Watanabe G, Watanabe N, Fujisawa K, Morii N, Madaule P, Narumiya S (1996) Rho-tekoin, a new putative target for Rho bearing homology to a serine/threonine kinase, PTN, and rhophilin in the Rho-binding domain. J Biol Chem 271:13556-13560
17. Riddley AJ, Hall A (1994) Signal transduction pathways regaluting Rho-mediated stress fibre formation: requirement for a tyrosine kinase. EMBO J 13:2600-2610
18. Sakurada S, Okamoto H, Takuwa N, Sugimoto N, Takuwa Y (2001) Rho activation in excitatory agonist-stimulated vascular smooth muscle. Am J Cell Physiol 281:C571-C578
19. Seasholtz TM, Majumdar M, Kaplan DD, Brown JH (1999) Rho and Rho Kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synhesis and migration. Circ Res 84:1186-1193
20. Seraj MJ, Harding MA, Gildea JJ, Welch DR, Theodorescu D (2000) The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin Exp Metastasis 18:519-525
21. Suwa H, Ohshio G, Imamura T, Watanabe G, Arii S, Imamura M, Narumiya S, Hiai H, Fukumoto M (1998) Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 77:147-152
22. Van Aelst L, D'Souza-Schorey C (1997) Rho GTPases and signaling networks. Genes Dev 11:2295-2322
23. Yossepowitch O, Dalbagni G (2002) Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. J Urol 168:61-66